Gritstone Oncology's Series B Round

Gritstone Oncology raised a round of funding on September 07, 2017.

Gritstone Oncology (NASDAQ Global: GRTS) is a personalized cancer immunotherapy company that is advancing the field of immuno-oncology to fight cancer in patients with the most difficult-to-treat tumo…

Articles about Gritstone Oncology's Series B Round: